Concurrent Investment Advisors’s Aspen Aerogels ASPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$103K Buy
30,050
+50
+0.2% +$169 ﹤0.01% 1823
2025
Q4
$84.9K Buy
+30,000
New +$155K ﹤0.01% 1718
2025
Q3
Sell
-17,604
Closed -$104K 1505
2025
Q2
$104K Buy
17,604
+511
+3% +$2.94K ﹤0.01% 1327
2025
Q1
$109K Buy
+17,093
New +$165K ﹤0.01% 1176

Other funds holding ASPN

Concurrent Investment Advisors's ASPN Position: Q1 2026 in Review

Concurrent Investment Advisors increased its Aspen Aerogels (ASPN) stake by 0.17% in Q1 2026, buying an estimated $169 and bringing the position to 30,050 shares worth $103K. The position accounts for ﹤0.01% of the portfolio, ranked #1823.

Concurrent Investment Advisors first reported a position in ASPN in Q1 2025 and has held it in 4 quarters since. The position peaked at $109K in Q1 2025. 166 funds tracked by Wall St. Rank hold ASPN as of Q1 2026.

  • Concurrent Investment Advisors held 30,050 shares of Aspen Aerogels worth $103K as of Q1 2026.
  • Concurrent Investment Advisors bought 50 Aspen Aerogels shares in Q1 2026, an estimated $169.
  • Aspen Aerogels made up ﹤0.01% of Concurrent Investment Advisors's portfolio in Q1 2026, its #1823 holding.
  • Concurrent Investment Advisors first reported a position in Aspen Aerogels in Q1 2025 and has held it in 4 quarters since.
  • Concurrent Investment Advisors's Aspen Aerogels position peaked at $109K in Q1 2025.
  • 166 funds tracked by Wall St. Rank held Aspen Aerogels as of Q1 2026.

Based on Concurrent Investment Advisors's 13F filing for Q1 2026, filed 21 Apr 2026.